Friday, March 1, 2013

Lab21 to Develop microRNA-Based Colorectal Cancer Diagnostic ...

Svante P??bo has been chosen as winner of the 2013 Genetics Prize of the Gruber Foundation, an accolade that includes a $500,000 award. P??bo, who is director of the Department of Genetics at the Max Planck Institute for Evolutionary Anthropology, won the award because of his pioneering efforts in the field of molecular paleontology, which uses genomics technologies and approaches to study prehistoric life.


CombiMatrix said this week that Chief Commercial Officer Mark McDonough will take over as CEO effective March 15. He succeeds Judd Jessup, who is retiring. McDonough joined CombiMatrix in August 2012 from Pathwork Diagnostics, where he was VP of sales, customer service, and training. He also has worked for US Labs, Dianon, Laboratory Corporation of America, EMC, and Ventana Medical Systems.


Nanosphere said this week in its financial report that it has promoted Michael McGarrity to succeed William Moffitt as its new president and CEO. The company also said it has appointed Sheli Rosenberg, Michael Ward, and McGarrity to serve on its board of directors, while Moffitt, William White, Mark Slezak, and Roy Davis have all resigned from the board. Rosenberg, who served on Nanosphere's board from 2002 to 2012, will be the new chair of the board. McGarrity previously was VP of sales and marketing and chief commercial officer, and he has 24 years of experience in the medical devices industry, including 13 years at Stryker.

Source: http://www.genomeweb.com/rnai/lab21-develop-microrna-based-colorectal-cancer-diagnostic-integragen

randy moss superbowl commercials OJ Brigance What Time Does The Superbowl Start 2013 Psalm 91 Super Bowl 2013 Commercials Evasi0n

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.